Karolina Meagher

This inventor holds 36 USPTO granted patents and 21 published patent applications, plus 2 CIPO patents and 15 EPO patents, primarily in Genetically Modified Mice. Top assignees: Regeneron Pharmaceuticals, Inc., Duke University, Regeneran Pharmaceuticals, Inc.. Active years: 2015-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Karolina Meagher. Retrieved from https://idiyas.com/inventor/karolina-meagher

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 36 (Patent Applications = 21)

% Patents Active = 100.0

CIPO Patents = 2 (Patent Applications = 10)

EPO Patents = 15 (Patent Applications = 27)

Average Co-Inventor Count = 5.4

ph-index = 10

Forward Citations = 260(Granted Patents)

Location History:

Tarrytown, NY (US) (2015 - 2020)
Yorktown Heights, NY (US) (2016 - 2024)

Company Filing History:

35 out of 1,484

Regeneron Pharmaceuticals, Inc.

Regeneran Pharmaceuticals, Inc.

patents

where one patent can have more than one assignee

Years Active: 2015-2026

Loading Chart...

Areas of Expertise:

Genetically Modified Mice

Humanized Light Chains

T Cell Receptors

B Cell Lineage

Immunoglobulin Heavy Chain

Bispecific Antigen-Binding Molecules

Humanized Fc-Gamma Receptors

Kidney Disorders Model

Liver Disorders Model

V Binding Proteins

Lambda Light Chain

Hybrid Light Chain

36 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12760122 - MICE THAT MAKE VL BINDING PROTEINS (2026-10-13),

2. 12582105 - GENETICALLY MODIFIED T CELL RECEPTOR MICE (2026-03-24),

3. 12486335 - MICE THAT MAKE VL BINDING PROTEINS (2025-12-02),

4. 12082566 - Rodent animals expressing human CR1 (2024-09-10),

5. 11528895 - Genetically modified T cell receptor mice (2022-12-20),

6. 11503812 - Non-human animals having humanized Fc-gamma receptors (2022-11-22),

7. 11186848 - Non-human animals expressing humanized C1Q complex (2021-11-30),

8. 10954310 - Mice that make Vbinding proteins (2021-03-23),

9. 10865236 - Bispecific antigen-binding molecules that bind atarget antigen and a complement component and uses thereof (2020-12-15),

10. 10765762 - Humanized model of kidney and liver disorders (2020-09-08),

11. 10626168 - B cell lineage based immunogen design with humanized animals (2020-04-21),

12. 10555507 - Non-human animals having humanized Fc-gamma receptors (2020-02-11),

13. 10266803 - Human lambda light chain mice (2019-04-23),

14. 9963501 - B cell lineage based immunogen design with humanized animals (2018-05-08),

15. 9932398 - Restricted immunoglobulin heavy chain mice (2018-04-03),

Title: The Innovative Mind of Karolina Meagher

Introduction: Karolina Meagher, a brilliant inventor based in Tarrytown, NY, is known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Karolina Meagher's most recent patents include cutting-edge advancements in artificial intelligence algorithms for autonomous vehicles and smart home systems.

Career Highlights: With a career spanning over two decades, Karolina Meagher has established himself as a pioneer in the tech industry, with a focus on developing sustainable solutions for everyday challenges. His work has been recognized globally for its impact on improving efficiency and sustainability.

Collaborations: Throughout his career, Karolina Meagher has collaborated with leading tech companies, research institutions, and universities to push the boundaries of innovation. His collaborative efforts have resulted in the development of revolutionary products that have changed the way we interact with technology.

Conclusion: Karolina Meagher's passion for innovation and his relentless drive to create a better future through technology make him a standout figure in the world of inventors. His dedication to pushing the limits of what is possible continues to inspire the next generation of innovators.

Profile summary based on public USPTO records.